When medical cannabis was rescheduled last November the Secretary of State for Health and Social Care announced that NICE were to produce long-term guidelines for cannabis-based medicinal products. Sapphire Medical Clinic is a registered stakeholder in this process. You can read the guidelines here:
The National Institute of Care Excellence draft guidelines for cannabis-based medicinal products, 8th August 2019 –
https://www.nice.org.uk/guidance/GID-NG10124/documents/draft-guideline
The Secretary of State also commissioned an NHS England review earlier this year into the barriers preventing access to cannabis-based medicinal products since the rescheduling. You can read the review here:
The NHS Review into Barriers preventing patient access to cannabis-based medicinal products, 8th August 2019 – https://www.england.nhs.uk/wp-content/uploads/2019/08/barriers-accessing-cannabis-based-products-nhs-prescription.pdf
